H
Hodaka Yamakado
Researcher at Kyoto University
Publications - 54
Citations - 1147
Hodaka Yamakado is an academic researcher from Kyoto University. The author has contributed to research in topics: Parkinson's disease & Substantia nigra. The author has an hindex of 16, co-authored 44 publications receiving 764 citations. Previous affiliations of Hodaka Yamakado include University of California, San Diego.
Papers
More filters
Journal ArticleDOI
Inoculation of α-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve
Norihito Uemura,Hisashi Yagi,Maiko T. Uemura,Yusuke Hatanaka,Hodaka Yamakado,Ryosuke Takahashi +5 more
TL;DR: Results indicate that α-Syn PFF inoculation into the mouse gastrointestinal tract can induce α- synuclein pathology resembling that of very early PD, but other factors are apparently required if further progression of PD pathology is to be replicated in this animal model.
Journal ArticleDOI
A progressive dopaminergic phenotype associated with neurotoxic conversion of α-synuclein in BAC-transgenic rats
Silke Nuber,Silke Nuber,Florian Harmuth,Zacharias Kohl,Anthony Adame,Margaritha Trejo,Kai Schönig,Frank Zimmermann,Claudia S. Bauer,Nicolas Casadei,Christiane Giel,Carsten Calaminus,Bernd J. Pichler,Poul Henning Jensen,Christian Müller,Davide Amato,Johannes Kornhuber,Peter Teismann,Hodaka Yamakado,Ryosuke Takahashi,J. Winkler,Eliezer Masliah,Olaf Riess +22 more
TL;DR: Ageing promoted conversion of both full-length and C-terminally truncated α-synuclein species into insolube and proteinase K-resistant fibres, with strongest accumulation in the striatum, resembling biochemical changes seen in human Parkinson's disease.
Journal ArticleDOI
Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammation.
Changyoun Kim,Changyoun Kim,Changyoun Kim,Brian Spencer,Edward Rockenstein,Hodaka Yamakado,Michael Mante,Anthony Adame,Jerel Adam Fields,Deborah Masliah,Michiyo Iba,He Jin Lee,Robert A. Rissman,Seung-Jae Lee,Eliezer Masliah,Eliezer Masliah +15 more
TL;DR: This study proposes TLR2 immunotherapy as a novel therapeutic strategy for synucleinopathies of the aging population and demonstrated that administration of anti-TLR2 alleviated α-synuclein accumulation in neuronal and astroglial cells, neuroinflammation, neurodegeneration, and behavioral deficits in an α- Synuclein tg mouse model of PD/DLB.
Journal ArticleDOI
Cellular internalization of alpha-synuclein aggregates by cell surface heparan sulfate depends on aggregate conformation and cell type.
Elisabet Ihse,Hodaka Yamakado,Xander M R van Wijk,Xander M R van Wijk,Roger Lawrence,Jeffrey D. Esko,Eliezer Masliah +6 more
TL;DR: It is shown, using a pH-sensitive probe, that internalization of α-synuclein amyloid fibrils in neuroblastoma cells is dependent on heparan sulfate, whereasInternalization of smaller non-amyloid oligomers is not, and overall sulfation of the heparans sulfate chains is more important than sulfation at particular sites along the chains.
Journal ArticleDOI
Viable neuronopathic Gaucher disease model in Medaka (Oryzias latipes) displays axonal accumulation of alpha-synuclein.
Norihito Uemura,Masato Koike,Satoshi Ansai,Masato Kinoshita,Tomoko Ishikawa-Fujiwara,Hideaki Matsui,Kiyoshi Naruse,Naoaki Sakamoto,Yasuo Uchiyama,Takeshi Todo,Shunichi Takeda,Hodaka Yamakado,Ryosuke Takahashi +12 more
TL;DR: GBA-/- medaka is revealed as a novel neuronopathic GD model, the pahological mechanisms of α-syn accumulation caused by GCase deficiency, and the minimal contribution ofα-syn to the pathogenesis of neuronopathicGD are revealed.